Wip1 suppresses apoptotic cell death through direct dephosphorylation of BAX in response to γ-radiation

Cell Death and Disease

Volumn 4, Issue 8, 2013, Pages

  Song, J Y ^a   Ryu, S H ^a   Cho, Y M ^a   Kim, Y S ^a   Lee, B M ^b   Lee, S W ^a   Choi, J ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Dongguk University   (South Korea)

Author keywords

Apoptosis; BAX; Ionizing radiation; Protein phosphates 2C; Wip1

Indexed keywords

PHOSPHATASE; PROTEIN BAX; UNCLASSIFIED DRUG; WIP1 PROTEIN;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL DEATH; CELL STRAIN LNCAP; DNA DAMAGE CHECKPOINT; GAMMA RADIATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DEPHOSPHORYLATION; PROTEIN DEPLETION; PROTEIN INTERACTION; RADIOSENSITIVITY;

EID: 84882655544     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2013.252     Document Type: Article

References (37)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA-Cancer J Clin 2009; 59: 225-249
2. Pieters BR, de Back DZ, Koning CC, Zwinderman AH. Comparison of three radiotherapy modalities on biochemical control and overall survival for the treatment of prostate cancer: A systematic review. J Eur Soc Therap Radiol Oncol 2009; 93: 168-173
3. Fiscella M, Zhang H, Fan S, Sakaguchi K, Shen S, Mercer WE et al. Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner. Proc Natl Acad Sci USA 1997; 94: 6048-6053 (Pubitemid 27270633)
4. Choi J, Appella E, Donehower LA. The structure and expression of the murine wildtype p53-induced phosphatase 1 (Wip1) gene. Genomics 2000; 64: 298-306 (Pubitemid 30212630)
5. Takekawa M, Adachi M, Nakahata A, Nakayama I, Itoh F, Tsukuda H et al. P53-inducible wip1 phosphatase mediates a negative feedback regulation of p38 MAPK-p53 signaling in response to UV radiation. EMBO J 2000; 19: 6517-6526
6. Park JY, Song JY, Kim HM, Han HS, Seol HS, Jang SJ et al. P53-independent expression of wild-Type p53-induced phosphatase 1 (Wip1) in methylmethane sulfonate-Treated cancer cell lines and human tumors. Int J Biochem Cell Biol 2012; 44: 896-904
7. Rossi M, Demidov ON, Anderson CW, Appella E, Mazur SJ. Induction of PPM1D following DNA-damaging treatments through a conserved p53 response element coincides with a shift in the use of transcription initiation sites. Nucleic Acids Res 2008; 36: 7168-7180
8. Lu X, Nannenga B, Donehower LA. PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints. Genes Dev 2005; 19: 1162-1174 (Pubitemid 40696183)
9. 2 kinase by the oncogenic Wip1 phosphatase. Cell Death Differ 2006; 13: 1170-1180 (Pubitemid 43905597)
10. Lu X, Bocangel D, Nannenga B, Yamaguchi H, Appella E, Donehower LA. The p53-induced oncogenic phosphatase PPM1D interacts with uracil DNA glycosylase and suppresses base excision repair. Mol Cell 2004; 15: 621-634 (Pubitemid 39141788)
11. Lu X, Nguyen TA, Donehower LA. Reversal of the ATM/ATR-mediated DNA damage response by the oncogenic phosphatase PPM1D. Cell Cycle (Georgetown, TX) 2005; 4: 1060-1064 (Pubitemid 41365366)
12. Lu X, Ma O, Nguyen TA, Jones SN, Oren M, Donehower LA. The Wip1 phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop. Cancer Cell 2007; 12: 342-354 (Pubitemid 47539308)
13. Macurek L, Lindqvist A, Voets O, Kool J, Vos HR, Medema RH. Wip1 phosphatase is associated with chromatin and dephosphorylates gammaH2AX to promote checkpoint inhibition. Oncogene 2010; 29: 2281-2291
14. Moon SH, Lin L, Zhang X, Nguyen TA, Darlington Y, Waldman AS et al. Wild-Type p53-induced phosphatase 1 dephosphorylates histone variant gamma-H2AX and suppresses DNA double strand break repair. J Biol Chem 2010; 285: 12935-12947
15. Moon SH, Nguyen TA, Darlington Y, Lu X, Donehower LA. Dephosphorylation of gamma-H2AX by WIP1: An important homeostatic regulatory event in DNA repair and cell cycle control. Cell Cycle (Georgetown, TX) 2010; 9: 2092-2096
16. Bulavin DV, Demidov ON, Saito S, Kauraniemi P, Phillips C, Amundson SA et al. Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity. Nat Genet 2002; 31: 210-215
17. Lu X, Nguyen TA, Moon SH, Darlington Y, Sommer M, Donehower LA. The type 2C phosphatase Wip1: An oncogenic regulator of tumor suppressor and DNA damage response pathways. Cancer Metast Rev 2008; 27: 123-135
18. 6 as novel independent prognostic marker in medulloblastoma. J Clin Oncol 2005; 23: 8853-8862 (Pubitemid 46211532)
19. Shreeram S, Demidov ON, Hee WK, Yamaguchi H, Onishi N, Kek C et al. Wip1 phosphatase modulates ATM-dependent signaling pathways. Mol Cell 2006; 23: 757-764 (Pubitemid 44308587)
20. Batchelor E, Mock CS, Bhan I, Loewer A, Lahav G. Recurrent initiation: A mechanism for triggering p53 pulses in response to DNA damage. Mol Cell 2008; 30: 277-289 (Pubitemid 351615316)
21. 2-dependent apoptosis in p53-negative tumors and protects normal tissues during treatment with anticancer agents. Proc Natl Acad Sci USA 2012; 109: E68-E75
22. Goloudina AR, Mazur SJ, Appella E, Garrido C, Demidov ON. Wip1 sensitizes p53-negative tumors to apoptosis by regulating the Bax/Bcl-xL ratio. Cell Cycle (Georgetown, TX) 2012; 11: 1883-1887
23. Jurgensmeier JM, Xie Z, Deveraux Q, Ellerby L, Bredesen D, Reed JC. Bax directly induces release of cytochrome c from isolated mitochondria. Proc Natl Academy of Sci USA 1998; 95: 4997-5002 (Pubitemid 28208539)
24. Gardai SJ, Hildeman DA, Frankel SK, Whitlock BB, Frasch SC, Borregaard N et al. Phosphorylation of Bax Ser184 by Akt regulates its activity and apoptosis in neutrophils. J Biol Chem 2004; 279: 21085-21095 (Pubitemid 38656511)
25. Xin M, Gao F, May WS, Flagg T, Deng X. Protein kinase Czeta abrogates the proapoptotic function of Bax through phosphorylation. J Biol Chem 2007; 282: 21268-21277 (Pubitemid 47099961)
26. Kim BJ, Ryu SW, Song BJ. JNK-And p38 kinase-mediated phosphorylation of Bax leads to its activation and mitochondrial translocation and to apoptosis of human hepatoma HepG2 cells. J Biol Chem 2006; 281: 21256-21265
27. Linseman DA, Butts BD, Precht TA, Phelps RA, Le SS, Laessig TA et al. Glycogen synthase kinase-3beta phosphorylates Bax and promotes its mitochondrial localization during neuronal apoptosis. Off J Soc Neurosci 2004; 24: 9993-10002 (Pubitemid 39463581)
28. Garzotto M, Haimovitz-Friedman A, Liao WC, White-Jones M, Huryk R, Heston WD et al. Reversal of radiation resistance in LNCaP cells by targeting apoptosis through ceramide synthase. Cancer Res 1999; 59: 5194-5201 (Pubitemid 29503982)
29. Xia Y, Ongusaha P, Lee SW, Liou YC. Loss of Wip1 sensitizes cells to stress-And DNA damage-induced apoptosis. J Biol Chem 2009; 284: 17428-17437
30. Wang Q, Sun SY, Khuri F, Curran WJ, Deng X. Mono-or double-site phosphorylation distinctly regulates the proapoptotic function of Bax. PLoS One 2010; 5: E13393
31. Blom N, Gammeltoft S, Brunak S. Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J Mol Biol 1999; 294: 1351-1362 (Pubitemid 30008805)
32. 2/p53-mediated apoptosis by inhibiting oncogenic Wip1 phosphatase. J Biol Chem 2008; 283: 18969-18979
33. Ali AY, Abedini MR, Tsang BK. The oncogenic phosphatase PPM1D confers cisplatin resistance in ovarian carcinoma cells by attenuating checkpoint kinase 1 and p53 activation. Oncogene 2012; 31: 2175-2186
34. Park HK, Panneerselvam J, Dudimah FD, Dong G, Sebastian S, Zhang J et al. Wip1 contributes to cell homeostasis maintained by the steady-state level of Wtp53. Cell Cycle (Georgetown, TX) 2011; 10: 2574-2582
35. Yamaguchi H, Durell SR, Chatterjee DK, Anderson CW, Appella E. The Wip1 phosphatase PPM1D dephosphorylates SQ/TQ motifs in checkpoint substrates phosphorylated by PI3K-like kinases. Biochemistry 2007; 46: 12594-12603 (Pubitemid 350064221)
36. Walensky LD, Gavathiotis E. BAX unleashed: The biochemical transformation of an inactive cytosolic monomer into a toxic mitochondrial pore. Trends Biochem Sci 2011; 36: 642-652
37. Xin M, Deng X. Protein phosphatase 2A enhances the proapoptotic function of Bax through dephosphorylation. J Biol Chem 2006; 281: 18859-18867 (Pubitemid 44035545)